Erratum

Erratum for the Research Article: “Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo” by J. L. Garrido, J. Presscott, M. Calvo, F. Bravo, R. Alvarez, A. Salas, R. Riquelme, M. L. Rioseco, B. N. Williamson, E. Haddock, H. Feldmann, M. I. Barria

See allHide authors and affiliations

Science Translational Medicine  16 Jan 2019:
Vol. 11, Issue 475, eaaw4903
DOI: 10.1126/scitranslmed.aaw4903

In the Discussion of the Research Article “Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo,” one sentence was updated from “In contrast, human recombinant Abs isolated from subjects who have survived infection have the advantages to be somatically hypermutated, whereas Abs derived from immunization do not have (43)” to “In contrast, human recombinant Abs isolated from subjects who have survived infection have the advantage of being effective and naturally optimized (43).” The PDF and HTML (full text) have been corrected.

Navigate This Article